What happens if i stop taking synthroid
Pro Research Analysisby 
Searched over 200M research papers
Effects of Discontinuing Synthroid: Clinical Outcomes and Risks
Synthroid® (levothyroxine) is a commonly prescribed medication for hypothyroidism, a condition where the thyroid gland does not produce enough thyroid hormone. Discontinuing or switching from Synthroid® to another formulation of levothyroxine can have significant clinical implications. This article synthesizes findings from multiple studies to highlight the potential risks and outcomes associated with stopping Synthroid®.
Increased Risk of Adverse Clinical Outcomes
Research indicates that patients who switch from Synthroid® to an alternative levothyroxine formulation are at a higher risk of experiencing negative clinical outcomes. A large retrospective study analyzed data from 19,850 patients and found that those who switched were 23% more likely to encounter adverse clinical outcomes compared to continuous users of Synthroid® . These adverse outcomes include chronic kidney disease (CKD), depression, fatigue, hypertension, and obesity .
Thyroid-Stimulating Hormone (TSH) Levels
Maintaining TSH levels within the guideline-recommended range is crucial for managing hypothyroidism effectively. Studies show that patients who switch from Synthroid® are significantly more likely to have TSH levels outside the recommended range. Specifically, switchers had an odds ratio of 1.15 for having out-of-range TSH levels compared to continuous users . This imbalance in TSH levels can lead to various health complications and undermine the management of hypothyroidism.
Specific Health Risks
Switching from Synthroid® has been associated with an increased likelihood of specific health issues. The studies found that switchers were more likely to be diagnosed with CKD, depression, fatigue, hypertension, and obesity in the two years following the switch . These conditions can significantly impact a patient's quality of life and overall health, emphasizing the importance of consistent medication use.
Clinical Guidelines and Recommendations
The findings from these studies support clinical guidelines that recommend avoiding switches between different formulations of levothyroxine. Continuous use of Synthroid® is associated with better clinical outcomes and a higher likelihood of maintaining TSH levels within the recommended range . Healthcare providers are advised to consider these risks when managing patients with hypothyroidism and to prioritize consistent use of Synthroid® to avoid potential adverse outcomes.
Conclusion
Discontinuing or switching from Synthroid® to another levothyroxine formulation can lead to significant health risks, including higher chances of adverse clinical outcomes and imbalanced TSH levels. Continuous use of Synthroid® is recommended to maintain optimal thyroid function and overall health. Patients should consult their healthcare providers before making any changes to their medication regimen to ensure the best possible outcomes.
Sources and full results
Most relevant research papers on this topic